Unknown PHASE2 INTERVENTIONAL 2-arm NCT03732365

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

A Phase 2 Randomized Study to Compare the Efficacy and Safety of Ultrasonic Drug Delivery to Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Chronic Non-Healing Wounds

Sponsor: Sonescence, Inc.

Conditions Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Non-healing Wound

Interventions Standard of Care Antibiotic Treatment Ultrasonic Drug Delivery

Updated 6 times since 2018 Last updated: Nov 4, 2018 Started: Feb 1, 2019 Primary completion: Jan 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03732365, this PHASE2 trial focuses on Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and Non-healing Wound and remains ongoing. Sponsored by Sonescence, Inc., it has been updated 6 times since 2019, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Dec 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Feb 2020 — Dec 2020 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Dec 2018 — Feb 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sonescence, Inc.
University of Southern California

Data source: Sonescence, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.